Atorvastatin PowerPoint PPT Presentations

All Time
Show:
Recommended
Sort by:
Atorvastatin Impurity | Atorvastatin Epoxy Tetrahydrofuran Analog PowerPoint PPT Presentation
Atorvastatin Impurity | Atorvastatin Epoxy Tetrahydrofuran Analog - Atorvastatin is used to reduce the levels of bad cholesterol and triglycerides in the blood. Here are some of the products of Atorvastatin which are widely used in the pharma industry like Atorvastatin Epoxy Tetrahydrofuran Analog, Atorvastatin FX1 Impurity, Atorvastatin FXA Impurity, & Atorvastatin Pyrrolidone Phenanthrene Calcium
Atorvastatin is used to reduce the levels of bad cholesterol and triglycerides in the blood. Here are some of the products of Atorvastatin which are widely used in the pharma industry like Atorvastatin Epoxy Tetrahydrofuran Analog, Atorvastatin FX1 Impurity, Atorvastatin FXA Impurity, & Atorvastatin Pyrrolidone Phenanthrene Calcium
| PowerPoint PPT presentation | free to download
Atorvastatin PowerPoint PPT Presentation
Atorvastatin - Title: No Slide Title Subject: Atorvastatin Author: Sarah Sampson Last modified by: Hewlett-Packard Created Date: 3/20/2000 10:28:09 AM Document presentation format
Title: No Slide Title Subject: Atorvastatin Author: Sarah Sampson Last modified by: Hewlett-Packard Created Date: 3/20/2000 10:28:09 AM Document presentation format
| PowerPoint PPT presentation | free to view
Atorvastatin Impurity PowerPoint PPT Presentation
Atorvastatin Impurity - Veeprho Pharmaceuticals s.r.o is a supplier of Atorvastatin Impurities like Trans Atorvastatin Impurity, Atorvastatin Lactone Impurity, Atorvastatin Related compound A, Atorvastatin Related compound B, Atorvastatin Related compound C, Atorvastatin Related compound D, Atorvastatin Related compound E etc.
Veeprho Pharmaceuticals s.r.o is a supplier of Atorvastatin Impurities like Trans Atorvastatin Impurity, Atorvastatin Lactone Impurity, Atorvastatin Related compound A, Atorvastatin Related compound B, Atorvastatin Related compound C, Atorvastatin Related compound D, Atorvastatin Related compound E etc.
| PowerPoint PPT presentation | free to view
Lipitor Atorvastatin PowerPoint PPT Presentation
Lipitor Atorvastatin - Lipitor (Atorvastatin) Team E: Jenna Hargens. Michael Harrington. Nick Herga. Ashley Holt ... Increased expression of LDL receptors on liver cells ...
Lipitor (Atorvastatin) Team E: Jenna Hargens. Michael Harrington. Nick Herga. Ashley Holt ... Increased expression of LDL receptors on liver cells ...
| PowerPoint PPT presentation | free to view
STERIS PHARMA | Atorvastatin: A Complete Guide to Uses & Side Effects PowerPoint PPT Presentation
STERIS PHARMA | Atorvastatin: A Complete Guide to Uses & Side Effects - Atorvastatin is used to raise the blood's HDL levels of good
Atorvastatin is used to raise the blood's HDL levels of good
| PowerPoint PPT presentation | free to download
Atorvastatin Impurities Manufacturer | Suppliers | Hemarsh Technologies PowerPoint PPT Presentation
Atorvastatin Impurities Manufacturer | Suppliers | Hemarsh Technologies - Atorvastatin Impurities Manufacturer and suppliers in India - Hemarsh Technologies was established in 2008 and since then our company has enjoyed a rapid growth. Our prime focus is on contract research and impurities synthesis for pharmaceutical industries.
Atorvastatin Impurities Manufacturer and suppliers in India - Hemarsh Technologies was established in 2008 and since then our company has enjoyed a rapid growth. Our prime focus is on contract research and impurities synthesis for pharmaceutical industries.
| PowerPoint PPT presentation | free to download
Collaborative Atorvastatin Diabetes Study CARDS PowerPoint PPT Presentation
Collaborative Atorvastatin Diabetes Study CARDS - Collaborative Atorvastatin Diabetes Study CARDS Helen Colhoun, John Betteridge, Paul Durrington, Graham Hitman, Andrew Neil, Shona Livingstone, Margaret Thomason ...
Collaborative Atorvastatin Diabetes Study CARDS Helen Colhoun, John Betteridge, Paul Durrington, Graham Hitman, Andrew Neil, Shona Livingstone, Margaret Thomason ...
| PowerPoint PPT presentation | free to download
Atorvastatin is Widely Prescribed PowerPoint PPT Presentation
Atorvastatin is Widely Prescribed - Atorvastatin is Widely Prescribed. Atorvastatin has been approved in over 50 countries ... atorvastatin: myalgia (3%) simvastatin: athralgia (7%) and chest pain (4 ...
Atorvastatin is Widely Prescribed. Atorvastatin has been approved in over 50 countries ... atorvastatin: myalgia (3%) simvastatin: athralgia (7%) and chest pain (4 ...
| PowerPoint PPT presentation | free to view
Atorvastatin API Market Research Report - Global Forecast till 2027 PowerPoint PPT Presentation
Atorvastatin API Market Research Report - Global Forecast till 2027 - The Global Atorvastatin API Market is expected to register a CAGR of 3.34% to reach USD 4,25,804.16 thousand by 2023.
The Global Atorvastatin API Market is expected to register a CAGR of 3.34% to reach USD 4,25,804.16 thousand by 2023.
| PowerPoint PPT presentation | free to download
Collaborative Atorvastatin Diabetes Study (CARDS) PowerPoint PPT Presentation
Collaborative Atorvastatin Diabetes Study (CARDS) - Men and women 40 75 years of age. Primary CHD and stroke prevention ... Albuminuria. Current smoking. Colhoun HM et al. Lancet 2004;364:685-696. Patient Population ...
Men and women 40 75 years of age. Primary CHD and stroke prevention ... Albuminuria. Current smoking. Colhoun HM et al. Lancet 2004;364:685-696. Patient Population ...
| PowerPoint PPT presentation | free to download
Chemical Structure of Atorvastatin PowerPoint PPT Presentation
Chemical Structure of Atorvastatin - ... size was assessed in the iliac-femoral artery of 8 hypercholesterolemic New ... Iliac-femoral cross-sectional. lesion area (mm2 mean SEM) ...
... size was assessed in the iliac-femoral artery of 8 hypercholesterolemic New ... Iliac-femoral cross-sectional. lesion area (mm2 mean SEM) ...
| PowerPoint PPT presentation | free to view
Collaborative Atorvastatin Diabetes Study CARDS PowerPoint PPT Presentation
Collaborative Atorvastatin Diabetes Study CARDS - ALT 3 ULN. 6. 4. AST 3 ULN. 0. 0. Rhabdomyolysis. 0. 1. 1. 1. CPK x 10 ULN ... Karen Almeida, Carol Austin, Pam Coward, Alison Dutton, Karen Delahaye, Philippa ...
ALT 3 ULN. 6. 4. AST 3 ULN. 0. 0. Rhabdomyolysis. 0. 1. 1. 1. CPK x 10 ULN ... Karen Almeida, Carol Austin, Pam Coward, Alison Dutton, Karen Delahaye, Philippa ...
| PowerPoint PPT presentation | free to view
CARDS: The Collaborative Atorvastatin Diabetes Study PowerPoint PPT Presentation
CARDS: The Collaborative Atorvastatin Diabetes Study - CARDS: The Collaborative Atorvastatin Diabetes Study
CARDS: The Collaborative Atorvastatin Diabetes Study
| PowerPoint PPT presentation | free to view
CARDS: The Collaborative Atorvastatin Diabetes Study PowerPoint PPT Presentation
CARDS: The Collaborative Atorvastatin Diabetes Study - Colhoun HM, Betteridge PN, Hitman GA et al. Primary prevention of cardiovascular ... to all cause mortality, major coronary events, coronary revascularization, ...
Colhoun HM, Betteridge PN, Hitman GA et al. Primary prevention of cardiovascular ... to all cause mortality, major coronary events, coronary revascularization, ...
| PowerPoint PPT presentation | free to view
Atorvastatin: Effective Therapy for a Broad Range of Dyslipidemias PowerPoint PPT Presentation
Atorvastatin: Effective Therapy for a Broad Range of Dyslipidemias - Marais AD et al. Atherosclerosis. 1994;109:316. Percent Change ... Marais AD et al. 12th DALM Symposium; Nov 7-10, 1995; Houston, Tex. Receptor Negative (N=2) ...
Marais AD et al. Atherosclerosis. 1994;109:316. Percent Change ... Marais AD et al. 12th DALM Symposium; Nov 7-10, 1995; Houston, Tex. Receptor Negative (N=2) ...
| PowerPoint PPT presentation | free to view
Atorvastatin is Effective Across a Broad Range of Hypercholesterolemic Patients PowerPoint PPT Presentation
Atorvastatin is Effective Across a Broad Range of Hypercholesterolemic Patients - Atorvastatin is Effective Across a Broad Range of ... Marais AD et al. Arterioscler Thromb Vasc Biol 1997;17:1527 1531. Change in lipids at 6 weeks ...
Atorvastatin is Effective Across a Broad Range of ... Marais AD et al. Arterioscler Thromb Vasc Biol 1997;17:1527 1531. Change in lipids at 6 weeks ...
| PowerPoint PPT presentation | free to view
Atorvastatin in Factorial with Omega-3 fatty acid Risk Reduction in Diabetes PowerPoint PPT Presentation
Atorvastatin in Factorial with Omega-3 fatty acid Risk Reduction in Diabetes - Title: PowerPoint Presentation Author: Diabetes Trials Unit Last modified by: Rury Holman Created Date: 3/14/2002 4:50:16 PM Document presentation format
Title: PowerPoint Presentation Author: Diabetes Trials Unit Last modified by: Rury Holman Created Date: 3/14/2002 4:50:16 PM Document presentation format
| PowerPoint PPT presentation | free to download
Differences in systolic and diastolic BP between patients randomized to atorvastatin or placebo PowerPoint PPT Presentation
Differences in systolic and diastolic BP between patients randomized to atorvastatin or placebo - Time point 0.87 0.0 0.95 ... Primary and secondary end points Differences in systolic and diastolic BP between patients randomized to atorvastatin or placebo Primary ...
Time point 0.87 0.0 0.95 ... Primary and secondary end points Differences in systolic and diastolic BP between patients randomized to atorvastatin or placebo Primary ...
| PowerPoint PPT presentation | free to download
Original Article HighDose Atorvastatin after Stroke or Transient Ischemic Attack PowerPoint PPT Presentation
Original Article HighDose Atorvastatin after Stroke or Transient Ischemic Attack - In this five-year placebo-controlled trial involving patients who had a recent ... low-density lipoprotein cholesterol levels of 100 to 190 mg per deciliter (3 to ...
In this five-year placebo-controlled trial involving patients who had a recent ... low-density lipoprotein cholesterol levels of 100 to 190 mg per deciliter (3 to ...
| PowerPoint PPT presentation | free to view
PROVE IT TIMI 22: Pravastatin or Atorvastatin Evaluation and Infection TherapyThrombolysis in Myocar PowerPoint PPT Presentation
PROVE IT TIMI 22: Pravastatin or Atorvastatin Evaluation and Infection TherapyThrombolysis in Myocar - PROVE IT: Pravastatin or Atorvastatin Evaluation and Infection Therapy - TRIAL DESIGN ... Prior statin therapy (%) Index event (%) Unstable angina. MI without ...
PROVE IT: Pravastatin or Atorvastatin Evaluation and Infection Therapy - TRIAL DESIGN ... Prior statin therapy (%) Index event (%) Unstable angina. MI without ...
| PowerPoint PPT presentation | free to view
Atorvastatin in Factorial with Omega-3 fatty acid Risk Reduction in Diabetes PowerPoint PPT Presentation
Atorvastatin in Factorial with Omega-3 fatty acid Risk Reduction in Diabetes - Funded by Pfizer, with data owned, analysed and reported by the University of ... Statistical analysis/publication. Pfizer UK. Protocol development. Regulatory aspects ...
Funded by Pfizer, with data owned, analysed and reported by the University of ... Statistical analysis/publication. Pfizer UK. Protocol development. Regulatory aspects ...
| PowerPoint PPT presentation | free to download
MDX PowerPoint PPT Presentation
MDX - ?????????. ??????. ????. ????????????,?????????????Benicar? ... ???????Cymbalta (Duloxetine),?????????? ???????????,????????????????????? Lipitor (Atorvastatin) ...
?????????. ??????. ????. ????????????,?????????????Benicar? ... ???????Cymbalta (Duloxetine),?????????? ???????????,????????????????????? Lipitor (Atorvastatin) ...
| PowerPoint PPT presentation | free to view
The Global Burden of Disease PowerPoint PPT Presentation
The Global Burden of Disease - ... Effect of atorvastatin ... High-risk Hypertensive Eligible for Lipid Lowering Atorvastatin 10 mg Placebo Randomize DB Randomized Amlodipine ...
... Effect of atorvastatin ... High-risk Hypertensive Eligible for Lipid Lowering Atorvastatin 10 mg Placebo Randomize DB Randomized Amlodipine ...
| PowerPoint PPT presentation | free to download
ASCOTLLA: AngloScandinavian Cardiac Outcomes Trial Lipid Lowering Arm PowerPoint PPT Presentation
ASCOTLLA: AngloScandinavian Cardiac Outcomes Trial Lipid Lowering Arm - To determine whether cholesterol lowering with atorvastatin reduces coronary ... Compared with placebo, atorvastatin lowered total cholesterol by 24% (50 mg/dL, ...
To determine whether cholesterol lowering with atorvastatin reduces coronary ... Compared with placebo, atorvastatin lowered total cholesterol by 24% (50 mg/dL, ...
| PowerPoint PPT presentation | free to view
Key point PowerPoint PPT Presentation
Key point - Atorvastatin safety is excellent and probably a gold standard for other statins ... Atorvastatin reveals clinical benefit with reduced cardiovascular events in ...
Atorvastatin safety is excellent and probably a gold standard for other statins ... Atorvastatin reveals clinical benefit with reduced cardiovascular events in ...
| PowerPoint PPT presentation | free to view
The PROVE IT Study PowerPoint PPT Presentation
The PROVE IT Study - 40mg of Pravastatin (Pravachol) or 80mg of Atorvastatin (Lipitor) ... More side effects with Atorvastatin. Future studies pending. Summary ...
40mg of Pravastatin (Pravachol) or 80mg of Atorvastatin (Lipitor) ... More side effects with Atorvastatin. Future studies pending. Summary ...
| PowerPoint PPT presentation | free to view
Effect on CETP inhibition on mean CE transfer rates (?g/CE/h/mL) PowerPoint PPT Presentation
Effect on CETP inhibition on mean CE transfer rates (?g/CE/h/mL) - A atorvastatin; A T atorvastatin torcetrapib. Mixed dyslipidemia. Effect of CETP inhibition on CE transfer capacity ( gCE/h/mg lipoprotein) ...
A atorvastatin; A T atorvastatin torcetrapib. Mixed dyslipidemia. Effect of CETP inhibition on CE transfer capacity ( gCE/h/mg lipoprotein) ...
| PowerPoint PPT presentation | free to view
ILLUMINATE Trial: Final Results PowerPoint PPT Presentation
ILLUMINATE Trial: Final Results - www.dave.md. ILLUMINATE Trial: Final Results. Adapted from ... www.dave.md. N=15,067. Torcetrapib 60mg Atorvastatin. N = 7,533. Atorvastatin Placebo ...
www.dave.md. ILLUMINATE Trial: Final Results. Adapted from ... www.dave.md. N=15,067. Torcetrapib 60mg Atorvastatin. N = 7,533. Atorvastatin Placebo ...
| PowerPoint PPT presentation | free to view
Diapositive 1 PowerPoint PPT Presentation
Diapositive 1 - ... Amlodipine + atorvastatine = CADUET , + valsartan = EXFORGE , + p rindopril = COVERAM , + olmesartan = SEVIKAR / AXELER , ...
... Amlodipine + atorvastatine = CADUET , + valsartan = EXFORGE , + p rindopril = COVERAM , + olmesartan = SEVIKAR / AXELER , ...
| PowerPoint PPT presentation | free to download
Statin metabolite and CCB show additive antioxidant effect PowerPoint PPT Presentation
Statin metabolite and CCB show additive antioxidant effect - ... of atorvastatin (100 nmol/L), lovastatin (100 nmol/L), and amlodipine (2.5 mol/L) ... Lovastatin. Amlodipine. Atorvastatin. metabolite. 40. 30. 20. 10. 0 ...
... of atorvastatin (100 nmol/L), lovastatin (100 nmol/L), and amlodipine (2.5 mol/L) ... Lovastatin. Amlodipine. Atorvastatin. metabolite. 40. 30. 20. 10. 0 ...
| PowerPoint PPT presentation | free to view
Treat Everyone to an LDLC of 70mgdl PowerPoint PPT Presentation
Treat Everyone to an LDLC of 70mgdl - ... C=Low density lipoprotein cholesterol; TNT=Treating to New Targets; HPS=Heart ... TNT (atorvastatin 80 mg/d) TNT (atorvastatin 10 mg/d) ... TNT and IDEAL ...
... C=Low density lipoprotein cholesterol; TNT=Treating to New Targets; HPS=Heart ... TNT (atorvastatin 80 mg/d) TNT (atorvastatin 10 mg/d) ... TNT and IDEAL ...
| PowerPoint PPT presentation | free to download
BEYOND LIFESTYLE CHANGES: THE ROLE OF AGGRESSIVE MEDICAL THERAPY FOR ALL PATIENTS AT INCREASED RISK FOR CARDIOVASCULAR DISEASE PowerPoint PPT Presentation
BEYOND LIFESTYLE CHANGES: THE ROLE OF AGGRESSIVE MEDICAL THERAPY FOR ALL PATIENTS AT INCREASED RISK FOR CARDIOVASCULAR DISEASE - This shows data from the STELLAR trial comparing rosuvastatin, atorvastatin, ... 16% 55% Increase in treatment of dyslipidemia: ...
This shows data from the STELLAR trial comparing rosuvastatin, atorvastatin, ... 16% 55% Increase in treatment of dyslipidemia: ...
| PowerPoint PPT presentation | free to download
Prof. dr Jovan Popovic PowerPoint PPT Presentation
Prof. dr Jovan Popovic - ... atorvastatin pravastatin fluvastatin lovastatin sa etak le enja angine pektoris 1. le iti uzrok 2. izbegavati faktore rizika 3. nitroglicerol 4.
... atorvastatin pravastatin fluvastatin lovastatin sa etak le enja angine pektoris 1. le iti uzrok 2. izbegavati faktore rizika 3. nitroglicerol 4.
| PowerPoint PPT presentation | free to download
BARCELLONA 6 OTTOBRE PowerPoint PPT Presentation
BARCELLONA 6 OTTOBRE - ... - Acyclovir - Captopril Captopril - - Enalapril - - Nifedipine - Ranitidine Ranitidine Cyclosporine - - Amlodipine Amlodipine - Atorvastatin ...
... - Acyclovir - Captopril Captopril - - Enalapril - - Nifedipine - Ranitidine Ranitidine Cyclosporine - - Amlodipine Amlodipine - Atorvastatin ...
| PowerPoint PPT presentation | free to view
Cardiovascular and Renal Drugs Advisory Committee Meeting PowerPoint PPT Presentation
Cardiovascular and Renal Drugs Advisory Committee Meeting - ... Amlodipine/Atorvastatin Improved Adherence with Combination Therapy: Metformin/Glyburide Improved Persistence with Combination Therapy: ...
... Amlodipine/Atorvastatin Improved Adherence with Combination Therapy: Metformin/Glyburide Improved Persistence with Combination Therapy: ...
| PowerPoint PPT presentation | free to view
The Drug Development Process: PowerPoint PPT Presentation
The Drug Development Process: - FDA relations Clinical safety assessment (phase 1 ... known SNPs in drug metabolism ... Pfizer's Torcetrapib/Atorvastatin Significantly Raised
FDA relations Clinical safety assessment (phase 1 ... known SNPs in drug metabolism ... Pfizer's Torcetrapib/Atorvastatin Significantly Raised
| PowerPoint PPT presentation | free to download
Changes in vessel-wall thickness and vessel-wall area in the thoracic aorta PowerPoint PPT Presentation
Changes in vessel-wall thickness and vessel-wall area in the thoracic aorta - Changes in vessel-wall thickness and vessel-wall area in the thoracic aorta p (20 mg vs 5 mg) Atorvastatin 5 mg (n=25 lesions) Atorvastatin 20 mg (n=25 lesions)
Changes in vessel-wall thickness and vessel-wall area in the thoracic aorta p (20 mg vs 5 mg) Atorvastatin 5 mg (n=25 lesions) Atorvastatin 20 mg (n=25 lesions)
| PowerPoint PPT presentation | free to download
TNT: Incidence of elevated liver or muscle enzymes PowerPoint PPT Presentation
TNT: Incidence of elevated liver or muscle enzymes - VBWG. TNT: Incidence of elevated liver. or muscle enzymes. Atorvastatin. 80 mg (%) (n = 4995) ... P 0.001 vs atorvastatin 10 mg. ALT = alanine ...
VBWG. TNT: Incidence of elevated liver. or muscle enzymes. Atorvastatin. 80 mg (%) (n = 4995) ... P 0.001 vs atorvastatin 10 mg. ALT = alanine ...
| PowerPoint PPT presentation | free to view
Transporters: Focus on OATP1B1 and Selected Renal Transporters PowerPoint PPT Presentation
Transporters: Focus on OATP1B1 and Selected Renal Transporters - OATP1B1: benzylpenicillin, atorvastatin,cerivastatin, fluvastatin, pitavastatin, ... MATE -1. Expression of Various Renal Transporters in Human Kidney ...
OATP1B1: benzylpenicillin, atorvastatin,cerivastatin, fluvastatin, pitavastatin, ... MATE -1. Expression of Various Renal Transporters in Human Kidney ...
| PowerPoint PPT presentation | free to download
The Challenge of Formulary Management in the DoD PowerPoint PPT Presentation
The Challenge of Formulary Management in the DoD - Comparison of non-equivalent doses of statins PROVE-IT trial compared 80 mg atorvastatin with 40 mg ... SPARCL 4D REVERSAL ASAP MIRACL PROVE-IT* TNT ...
Comparison of non-equivalent doses of statins PROVE-IT trial compared 80 mg atorvastatin with 40 mg ... SPARCL 4D REVERSAL ASAP MIRACL PROVE-IT* TNT ...
| PowerPoint PPT presentation | free to view
PrePharmacy Society Sixth General Body Meeting PowerPoint PPT Presentation
PrePharmacy Society Sixth General Body Meeting - ... (Pravachol), Simvastatin (Zocor), Atorvastatin (Lipitor), Rosuvastatin (Crestor) ... Naturally-occurring anticoagulant produced by the basophils and mastocyte ...
... (Pravachol), Simvastatin (Zocor), Atorvastatin (Lipitor), Rosuvastatin (Crestor) ... Naturally-occurring anticoagulant produced by the basophils and mastocyte ...
| PowerPoint PPT presentation | free to view
Alsheikh-Ali A et al. Circulation 2005; available at: http://circ.ahajournals.org. PowerPoint PPT Presentation
Alsheikh-Ali A et al. Circulation 2005; available at: http://circ.ahajournals.org. - Prescriptions (in millions) 315. 52. 381. 145. Adverse events (n) Atorvastatin. Pravastatin. Simvastatin. Rosuvastatin. Outcome ...
Prescriptions (in millions) 315. 52. 381. 145. Adverse events (n) Atorvastatin. Pravastatin. Simvastatin. Rosuvastatin. Outcome ...
| PowerPoint PPT presentation | free to download
Pharmacologic Strategy for Treating Patients with Diabetes and Vascular Disease: A Polypharmacy Appr PowerPoint PPT Presentation
Pharmacologic Strategy for Treating Patients with Diabetes and Vascular Disease: A Polypharmacy Appr - Useful in combo RX. Improves Insulin resistance at the hepatic level. TZDs Improve CV Risks ... CARDS, Collaborative Atorvastatin Diabetes Study. Colhoun HM, ...
Useful in combo RX. Improves Insulin resistance at the hepatic level. TZDs Improve CV Risks ... CARDS, Collaborative Atorvastatin Diabetes Study. Colhoun HM, ...
| PowerPoint PPT presentation | free to view
Atrovastatin API Market PowerPoint PPT Presentation
Atrovastatin API Market - The Global Atorvastatin API Market is estimated to be valued at USD 4,25,804.16 thousand by 2023 and is expected to register a CAGR of 3.34% during the forecast period.
The Global Atorvastatin API Market is estimated to be valued at USD 4,25,804.16 thousand by 2023 and is expected to register a CAGR of 3.34% during the forecast period.
| PowerPoint PPT presentation | free to download
STATINS POST STROKE: HOW MUCH IS ENOUGH? PowerPoint PPT Presentation
STATINS POST STROKE: HOW MUCH IS ENOUGH? - ... Drug & Non-drug Measures Continue with Atorvastatin 40 mg Reinitiate ASA 81 mg once ... diet Current Medications HTN Amlodipine 10 mg OD Ramipril 5 mg ...
... Drug & Non-drug Measures Continue with Atorvastatin 40 mg Reinitiate ASA 81 mg once ... diet Current Medications HTN Amlodipine 10 mg OD Ramipril 5 mg ...
| PowerPoint PPT presentation | free to download
Type 2 diabetes PowerPoint PPT Presentation
Type 2 diabetes - 0,4% 0,2% 3,6% 4,7% 5,4% 5,8% Atorvastatine 10 mg 0,9% 1,2% 2,4% 4,8% 7,0% 8,1% Atorvastatine 80 mg Stijging van de leverenzymen ** (ALT/AST3x ULN) ...
0,4% 0,2% 3,6% 4,7% 5,4% 5,8% Atorvastatine 10 mg 0,9% 1,2% 2,4% 4,8% 7,0% 8,1% Atorvastatine 80 mg Stijging van de leverenzymen ** (ALT/AST3x ULN) ...
| PowerPoint PPT presentation | free to view
JUPITER PowerPoint PPT Presentation
JUPITER - An Intervention Trial Evaluating ... (2.4) 0.01 0.25 0.5 1.0 2 4 WOSCOPS Pravastatine HPS Simvastatin e ASCOT-LLA Atorvastatine JUPITER Rosuvastatine PROVE-IT ...
An Intervention Trial Evaluating ... (2.4) 0.01 0.25 0.5 1.0 2 4 WOSCOPS Pravastatine HPS Simvastatin e ASCOT-LLA Atorvastatine JUPITER Rosuvastatine PROVE-IT ...
| PowerPoint PPT presentation | free to download
The 4 key sentences structure PowerPoint PPT Presentation
The 4 key sentences structure - Cholesterol biosynthesis is an integral part of HCV RNA replication. ... Although atorvastatin was effective at lowering cholesterol, it did not show a ...
Cholesterol biosynthesis is an integral part of HCV RNA replication. ... Although atorvastatin was effective at lowering cholesterol, it did not show a ...
| PowerPoint PPT presentation | free to view
Statins Reduce Vascular Injury in a Preclinical and Clinical Model of Arteriosclerosis PowerPoint PPT Presentation
Statins Reduce Vascular Injury in a Preclinical and Clinical Model of Arteriosclerosis - ... Atorvastatin significantly reduces vascular damage and degree of stenosis (p 0.05) ... Result 7. Increase of stenosis correlated with increase in the number of ...
... Atorvastatin significantly reduces vascular damage and degree of stenosis (p 0.05) ... Result 7. Increase of stenosis correlated with increase in the number of ...
| PowerPoint PPT presentation | free to view
??e? ??s? t? p???f?? PowerPoint PPT Presentation
??e? ??s? t? p???f?? - Amlodipine/atorvastatin single-pill therapy should therefore improve management of total CV risk in patients requiring BP-and lipid-lowering therapy. ...
Amlodipine/atorvastatin single-pill therapy should therefore improve management of total CV risk in patients requiring BP-and lipid-lowering therapy. ...
| PowerPoint PPT presentation | free to view
New Insights into the Benefits of Early Statin Initiation in Acute Coronary Syndromes PowerPoint PPT Presentation
New Insights into the Benefits of Early Statin Initiation in Acute Coronary Syndromes - AHA 2000, Late breaking clinical trials presentation. The PROVE IT (Pravastatin or Atorvastatin Evaluation and Infection Therapy) trial is a head-to-head trial, ...
AHA 2000, Late breaking clinical trials presentation. The PROVE IT (Pravastatin or Atorvastatin Evaluation and Infection Therapy) trial is a head-to-head trial, ...
| PowerPoint PPT presentation | free to view
Prescription des principaux hypolip PowerPoint PPT Presentation
Prescription des principaux hypolip - ... L atorvastatine dont les parts de march exprim es en % des boites ne se sont que l g rement rod es, toujours leader, ...
... L atorvastatine dont les parts de march exprim es en % des boites ne se sont que l g rement rod es, toujours leader, ...
| PowerPoint PPT presentation | free to download
High Cost Statin Prescribing and Cardiac Networks National Meeting 31st October 2006 PowerPoint PPT Presentation
High Cost Statin Prescribing and Cardiac Networks National Meeting 31st October 2006 - East Surrey / North Sussex Local Cardiac Care Network. Dr John V Howard. GPwSI Cardiology. East Surrey PCT. Ratio of simvastatin:(atorvastatin rosuvastatin) ...
East Surrey / North Sussex Local Cardiac Care Network. Dr John V Howard. GPwSI Cardiology. East Surrey PCT. Ratio of simvastatin:(atorvastatin rosuvastatin) ...
| PowerPoint PPT presentation | free to view
Thiazolidinediones en Insulineresistentie PowerPoint PPT Presentation
Thiazolidinediones en Insulineresistentie - survey of 144 primary ... Results : - LDL cholesterol lower in the atorvastatin-group (79 ... ADIPOSE TISSUE IS THE MOST IMPORTANT ACTION OF TZD. Mechanisme van ...
survey of 144 primary ... Results : - LDL cholesterol lower in the atorvastatin-group (79 ... ADIPOSE TISSUE IS THE MOST IMPORTANT ACTION OF TZD. Mechanisme van ...
| PowerPoint PPT presentation | free to view
DRUG-DRUG INTERACTIONS PowerPoint PPT Presentation
DRUG-DRUG INTERACTIONS - ... and CYPs OATP1B1 4.5 Pitavastatin CYP3A4/OATP1B1 7.0 Atorvastatin OATP1B1 8.0 Pravastatin CYP3A4 8.0 Simvastatin Presumed Mechanism AUC or Cmax Increase In ...
... and CYPs OATP1B1 4.5 Pitavastatin CYP3A4/OATP1B1 7.0 Atorvastatin OATP1B1 8.0 Pravastatin CYP3A4 8.0 Simvastatin Presumed Mechanism AUC or Cmax Increase In ...
| PowerPoint PPT presentation | free to view


Home About Us Terms and Conditions Privacy Policy Contact Us
Copyright 2024 CrystalGraphics, Inc. — All rights Reserved. PowerShow.com is a trademark of CrystalGraphics, Inc.
atorvastatin — Search results on PowerShow.com